Alpha/beta interferon (IFN-α/β) signaling in astrocytes mediates protection against viral encephalomyelitis and regulates IFN-γ- dependent responses

Journal of Virology

Volumn 92, Issue 10, 2018, Pages

  Hwang, Mihyun ^a   Bergmann, Cornelia C ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Astrocytes; CNS; IFN ; IFN ; IFNAR; MHV

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; GAMMA INTERFERON; MESSENGER RNA; PATTERN RECOGNITION RECEPTOR; ALPHA BETA INTERFERON RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN CELL LINE; CELL INFILTRATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; ENCEPHALITIS VIRUS; ENCEPHALOMYELITIS; ENZYME REGULATION; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; INTERFERON STIMULATED GENE; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MICROGLIA; MORTALITY RATE; MOUSE; MURINE HEPATITIS VIRUS; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; UPREGULATION; VIRUS GENE; VIRUS REPLICATION; VIRUS STRAIN; ANIMAL; C57BL MOUSE; CORONAVIRUS INFECTION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; VIROLOGY;

ANIMALS; ASTROCYTES; CENTRAL NERVOUS SYSTEM; CORONAVIRUS INFECTIONS; ENCEPHALOMYELITIS; INTERFERON-ALPHA; INTERFERON-BETA; INTERFERON-GAMMA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MURINE HEPATITIS VIRUS; RECEPTOR, INTERFERON ALPHA-BETA; SIGNAL TRANSDUCTION;

EID: 85046012868     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.001901-17     Document Type: Article

References (84)

1. Swanson PA, II, McGavern DB. 2015. Viral diseases of the central nervous system. Curr Opin Virol 11:44-54. https://doi.org/10.1016/j.coviro.2014 .12.009
2. Ivashkiv LB, Donlin LT. 2014. Regulation of type I interferon responses. Nat Rev Immunol 14:36-49. https://doi.org/10.1038/nri3581
3. Sorgeloos F, Kreit M, Hermant P, Lardinois C, Michiels T. 2013. Antiviral type I and type III interferon responses in the central nervous system. Viruses 5:834-857. https://doi.org/10.3390/v5030834
4. Crouse J, Kalinke U, Oxenius A. 2015. Regulation of antiviral T cell responses by type I interferons. Nat Rev Immunol 15:231-242. https:// doi.org/10.1038/nri3806
5. Paul S, Ricour C, Sommereyns C, Sorgeloos F, Michiels T. 2007. Type I interferon response in the central nervous system. Biochimie 89: 770-778. https://doi.org/10.1016/j.biochi.2007.02.009
6. Zegenhagen L, Kurhade C, Koniszewski N, Overby AK, Kroger A. 2016. Brain heterogeneity leads to differential innate immune responses and modulates pathogenesis of viral infections. Cytokine Growth Factor Rev 30:95-101. https://doi.org/10.1016/j.cytogfr.2016.03.006
7. Russo MV, McGavern DB. 2015. Immune surveillance of the CNS following infection and injury. Trends Immunol 36:637-650. https://doi.org/10 .1016/j.it.2015.08.002
8. Mogensen TH. 2009. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev 22:240-273, Table of Contents. https://doi.org/10.1128/CMR.00046-08
9. Akira S, Uematsu S, Takeuchi O. 2006. Pathogen recognition and innate immunity. Cell 124:783-801. https://doi.org/10.1016/j.cell.2006.02.015
10. Carty M, Reinert L, Paludan SR, Bowie AG. 2014. Innate antiviral signalling in the central nervous system. Trends Immunol 35:79-87. https:// doi.org/10.1016/j.it.2013.10.012
11. Kapil P, Butchi NB, Stohlman SA, Bergmann CC. 2012. Oligodendroglia are limited in type I interferon induction and responsiveness in vivo. Glia 60:1555-1566. https://doi.org/10.1002/glia.22375
12. Zurney J, Howard KE, Sherry B. 2007. Basal expression levels of IFNAR and Jak-STAT components are determinants of cell-type-specific differences in cardiac antiviral responses. J Virol 81:13668-13680. https://doi .org/10.1128/JVI.01172-07
13. Farina C, Aloisi F, Meinl E. 2007. Astrocytes are active players in cerebral innate immunity. Trends Immunol 28:138-145. https://doi.org/10.1016/ j.it.2007.01.005
14. Pfefferkorn C, Kallfass C, Lienenklaus S, Spanier J, Kalinke U, Rieder M, Conzelmann KK, Michiels T, Staeheli P. 2015. Abortively infected astrocytes appear to represent the main source of interferon beta in the virus-infected brain. J Virol 90:2031-2038. https://doi.org/10.1128/JVI.02979-15
15. Detje CN, Lienenklaus S, Chhatbar C, Spanier J, Prajeeth CK, Soldner C, Tovey MG, Schluter D, Weiss S, Stangel M, Kalinke U. 2015. Upon intranasal vesicular stomatitis virus infection, astrocytes in the olfactory bulb are important interferon beta producers that protect from lethal encephalitis. J Virol 89:2731-2738. https://doi.org/10.1128/JVI.02044-14
16. Kallfass C, Ackerman A, Lienenklaus S, Weiss S, Heimrich B, Staeheli P. 2012. Visualizing production of beta interferon by astrocytes and microglia in brain of La Crosse virus-infected mice. J Virol 86:11223-11230. https://doi.org/10.1128/JVI.01093-12
17. Claycomb KI, Johnson KM, Winokur PN, Sacino AV, Crocker SJ. 2013. Astrocyte regulation of CNS inflammation and remyelination. Brain Sci 3:1109-1127. https://doi.org/10.3390/brainsci3031109
18. Roth-Cross JK, Bender SJ, Weiss SR. 2008. Murine coronavirus mouse hepatitis virus is recognized by MDA5 and induces type I interferon in brain macrophages/microglia. J Virol 82:9829-9838. https://doi.org/10 .1128/JVI.01199-08
19. Abbott NJ, Ronnback L, Hansson E. 2006. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7:41-53. https://doi .org/10.1038/nrn1824
20. Sofroniew MV, Vinters HV. 2010. Astrocytes: biology and pathology. Acta Neuropathol 119:7-35. https://doi.org/10.1007/s00401-009-0619-8
21. Kraus J, Ling AK, Hamm S, Voigt K, Oschmann P, Engelhardt B. 2004. Interferon-beta stabilizes barrier characteristics of brain endothelial cells in vitro. Ann Neurol 56:192-205. https://doi.org/10.1002/ana.20161
22. Daniels BP, Jujjavarapu H, Durrant DM, Williams JL, Green RR, White JP, Lazear HM, Gale M, Jr, Diamond MS, Klein RS. 2017. Regional astrocyte IFN signaling restricts pathogenesis during neurotropic viral infection. J Clin Invest 127:843-856. https://doi.org/10.1172/JCI88720
23. McNab F, Mayer-Barber K, Sher A, Wack A, O'Garra A. 2015. Type I interferons in infectious disease. Nat Rev Immunol 15:87-103. https:// doi.org/10.1038/nri3787
24. Nayak D, Johnson KR, Heydari S, Roth TL, Zinselmeyer BH, McGavern DB. 2013. Type I interferon programs innate myeloid dynamics and gene expression in the virally infected nervous system. PLoS Pathog 9:e1003395. https://doi.org/10.1371/journal.ppat.1003395
25. Pinto AK, Daffis S, Brien JD, Gainey MD, Yokoyama WM, Sheehan KC, Murphy KM, Schreiber RD, Diamond MS. 2011. A temporal role of type I interferon signaling in CD8+ T cell maturation during acute West Nile virus infection. PLoS Pathog 7:e1002407. https://doi.org/10.1371/journal .ppat.1002407
26. Lavi E, Gilden DH, Highkin MK, Weiss SR. 1986. The organ tropism of mouse hepatitis virus A59 in mice is dependent on dose and route of inoculation. Lab Anim Sci 36:130-135
27. Zhao L, Rose KM, Elliott R, Van Rooijen N, Weiss SR. 2011. Cell-type-specific type I interferon antagonism influences organ tropism of murine coronavirus. J Virol 85:10058-10068. https://doi.org/10.1128/JVI.05075-11
28. Bender SJ, Weiss SR. 2010. Pathogenesis of murine coronavirus in the central nervous system. J Neuroimmune Pharmacol 5:336-354. https:// doi.org/10.1007/s11481-010-9202-2
29. Rose KM, Weiss SR. 2009. Murine coronavirus cell type dependent interaction with the type I interferon response. Viruses 1:689-712. https://doi.org/10.3390/v1030689
30. Daffis S, Szretter KJ, Schriewer J, Li J, Youn S, Errett J, Lin TY, Schneller S, Zust R, Dong H, Thiel V, Sen GC, Fensterl V, Klimstra WB, Pierson TC, Buller RM, Gale M, Jr, Shi PY, Diamond MS. 2010. 2'-O methylation of the viral mRNA cap evades host restriction by IFIT family members. Nature 468:452-456. https://doi.org/10.1038/nature09489
31. Butchi NB, Hinton DR, Stohlman SA, Kapil P, Fensterl V, Sen GC, Bergmann CC. 2014. Ifit2 deficiency results in uncontrolled neurotropic coronavirus replication and enhanced encephalitis via impaired alpha/ beta interferon induction in macrophages. J Virol 88:1051-1064. https:// doi.org/10.1128/JVI.02272-13
32. Ireland DD, Stohlman SA, Hinton DR, Atkinson R, Bergmann CC. 2008. Type I interferons are essential in controlling neurotropic coronavirus infection irrespective of functional CD8 T cells. J Virol 82:300-310. https://doi.org/10.1128/JVI.01794-07
33. Bergmann CC, Lane TE, Stohlman SA. 2006. Coronavirus infection of the central nervous system: host-virus stand-off. Nat Rev Microbiol 4:121-132. https://doi.org/10.1038/nrmicro1343
34. Baig E, Fish EN. 2008. Distinct signature type I interferon responses are determined by the infecting virus and the target cell. Antivir Ther 13:409-422
35. McKimmie CS, Johnson N, Fooks AR, Fazakerley JK. 2005. Viruses selectively upregulate Toll-like receptors in the central nervous system. Biochem Biophys Res Commun 336:925-933. https://doi.org/10.1016/j .bbrc.2005.08.209
36. Sharma A, Maheshwari RK. 2009. Oligonucleotide array analysis of Tolllike receptors and associated signalling genes in Venezuelan equine encephalitis virus-infected mouse brain. J Gen Virol 90:1836-1847. https://doi.org/10.1099/vir.0.010280-0
37. Li J, Liu Y, Zhang X. 2010. Murine coronavirus induces type I interferon in oligodendrocytes through recognition by RIG-I and MDA5. J Virol 84:6472-6482. https://doi.org/10.1128/JVI.00016-10
38. Mazaleuskaya L, Veltrop R, Ikpeze N, Martin-Garcia J, Navas-Martin S. 2012. Protective role of Toll-like receptor 3-induced type I interferon in murine coronavirus infection of macrophages. Viruses 4:901-923. https://doi.org/10.3390/v4050901
39. Honda K, Yanai H, Negishi H, Asagiri M, Sato M, Mizutani T, Shimada N, Ohba Y, Takaoka A, Yoshida N, Taniguchi T. 2005. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434:772-777. https://doi.org/10.1038/nature03464
40. Kimelberg HK. 2004. The problem of astrocyte identity. Neurochem Int 45:191-202. https://doi.org/10.1016/j.neuint.2003.08.015
41. Hosking MP, Lane TE. 2010. The role of chemokines during viral infection of the CNS. PLoS Pathog 6:e1000937. https://doi.org/10.1371/journal .ppat.1000937
42. Trinchieri G. 2010. Type I interferon: friend or foe? J Exp Med 207: 2053-2063. https://doi.org/10.1084/jem.20101664
43. Sun N, Grzybicki D, Castro RF, Murphy S, Perlman S. 1995. Activation of astrocytes in the spinal cord of mice chronically infected with a neurotropic coronavirus. Virology 213:482-493. https://doi.org/10.1006/viro .1995.0021
44. Yu D, Zhu H, Liu Y, Cao J, Zhang X. 2009. Regulation of proinflammatory cytokine expression in primary mouse astrocytes by coronavirus infection. J Virol 83:12204-12214. https://doi.org/10.1128/JVI.01103-09
45. Stock AT, Smith JM, Carbone FR. 2014. Type I IFN suppresses Cxcr2 driven neutrophil recruitment into the sensory ganglia during viral infection. J Exp Med 211:751-759. https://doi.org/10.1084/jem.20132183
46. Lane TE, Liu MT, Chen BP, Asensio VC, Samawi RM, Paoletti AD, Campbell IL, Kunkel SL, Fox HS, Buchmeier MJ. 2000. A central role for CD4(+) T cells and RANTES in virus-induced central nervous system inflammation and demyelination. J Virol 74:1415-1424. https://doi.org/10.1128/JVI.74 .3.1415-1424.2000
47. Phares TW, Stohlman SA, Hwang M, Min B, Hinton DR, Bergmann CC. 2012. CD4 T cells promote CD8 T cell immunity at the priming and effector site during viral encephalitis. J Virol 86:2416-2427. https://doi .org/10.1128/JVI.06797-11
48. Slifka MK, Whitton JL. 2000. Antigen-specific regulation of T cellmediated cytokine production. Immunity 12:451-457. https://doi.org/10 .1016/S1074-7613(00)80197-1
49. Slifka MK, Rodriguez F, Whitton JL. 1999. Rapid on/off cycling of cytokine production by virus-specific CD8+ T cells. Nature 401:76-79. https://doi .org/10.1038/43454
50. Schroder K, Hertzog PJ, Ravasi T, Hume DA. 2004. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 75: 163-189. https://doi.org/10.1189/jlb.0603252
51. LeibundGut-Landmann S, Waldburger JM, Krawczyk M, Otten LA, Suter T, Fontana A, Acha-Orbea H, Reith W. 2004. Specificity and expression of CIITA, the master regulator of MHC class II genes. Eur J Immunol 34:1513-1525. https://doi.org/10.1002/eji.200424964
52. O'Keefe GM, Nguyen VT, Benveniste EN. 1999. Class II transactivator and class II MHC gene expression in microglia: modulation by the cytokines TGF-beta, IL-4, IL-13 and IL-10. Eur J Immunol 29:1275-1285. https://doi.org/ 10.1002/(SICI)1521-4141(199904)29:04<1275::AID-IMMU1275>3.0.CO;2-T
53. Carter SL, Muller M, Manders PM, Campbell IL. 2007. Induction of the genes for Cxcl9 and Cxcl10 is dependent on IFN-gamma but shows differential cellular expression in experimental autoimmune encephalomyelitis and by astrocytes and microglia in vitro. Glia 55:1728-1739. https://doi.org/10.1002/glia.20587
54. Phares TW, Marques CP, Stohlman SA, Hinton DR, Bergmann CC. 2011. Factors supporting intrathecal humoral responses following viral encephalomyelitis. J Virol 85:2589-2598. https://doi.org/10.1128/JVI.02260-10
55. Groom JR, Luster AD. 2011. CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol Cell Biol 89:207-215. https://doi.org/10 .1038/icb.2010.158
56. Yarilina A, Park-Min KH, Antoniv T, Hu X, Ivashkiv LB. 2008. TNF activates an IRF1-dependent autocrine loop leading to sustained expression of chemokines and STAT1-dependent type I interferon-response genes. Nat Immunol 9:378-387. https://doi.org/10.1038/ni1576
57. Phares TW, Stohlman SA, Hinton DR, Bergmann CC. 2013. Astrocytederived CXCL10 drives accumulation of antibody-secreting cells in the central nervous system during viral encephalomyelitis. J Virol 87: 3382-3392. https://doi.org/10.1128/JVI.03307-12
58. Rayamajhi M, Humann J, Penheiter K, Andreasen K, Lenz LL. 2010. Induction of IFN-alphabeta enables Listeria monocytogenes to suppress macrophage activation by IFN-gamma. J Exp Med 207:327-337. https:// doi.org/10.1084/jem.20091746
59. Yoshida R, Murray HW, Nathan CF. 1988. Agonist and antagonist effects of interferon alpha and beta on activation of human macrophages. Two classes of interferon gamma receptors and blockade of the high-affinity sites by interferon alpha or beta. J Exp Med 167:1171-1185
60. Inaba K, Kitaura M, Kato T, Watanabe Y, Kawade Y, Muramatsu S. 1986. Contrasting effect of alpha/beta-and gamma-interferons on expression of macrophage Ia antigens. J Exp Med 163:1030-1035. https://doi.org/ 10.1084/jem.163.4.1030
61. Zhang Y, Chen K, Sloan SA, Bennett ML, Scholze AR, O'Keeffe S, Phatnani HP, Guarnieri P, Caneda C, Ruderisch N, Deng S, Liddelow SA, Zhang C, Daneman R, Maniatis T, Barres BA, Wu JQ. 2014. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J Neurosci 34:11929-11947. https://doi.org/10 .1523/JNEUROSCI.1860-14.2014
62. Gough DJ, Messina NL, Clarke CJ, Johnstone RW, Levy DE. 2012. Constitutive type I interferon modulates homeostatic balance through tonic signaling. Immunity 36:166-174. https://doi.org/10.1016/j.immuni.2012 .01.011
63. Daffis S, Suthar MS, Gale M, Jr, Diamond MS. 2009. Measure and countermeasure: type I IFN (IFN-alpha/beta) antiviral response against West Nile virus. J Innate Immun 1:435-445. https://doi.org/10.1159/ 000226248
64. Ma Y, Haynes RL, Sidman RL, Vartanian T. 2007. TLR8: an innate immune receptor in brain, neurons and axons. Cell Cycle 6:2859-2868. https:// doi.org/10.4161/cc.6.23.5018
65. Delhaye S, Paul S, Blakqori G, Minet M, Weber F, Staeheli P, Michiels T. 2006. Neurons produce type I interferon during viral encephalitis. Proc Natl Acad Sci U S A 103:7835-7840. https://doi.org/10.1073/pnas .0602460103
66. van den Pol AN, Ding S, Robek MD. 2014. Long-distance interferon signaling within the brain blocks virus spread. J Virol 88:3695-3704. https://doi.org/10.1128/JVI.03509-13
67. Jablonska J, Wu CF, Andzinski L, Leschner S, Weiss S. 2014. CXCR2-mediated tumor-associated neutrophil recruitment is regulated by IFNbeta. Int J Cancer 134:1346-1358. https://doi.org/10.1002/ijc.28551
68. Savarin C, Stohlman SA, Hinton DR, Ransohoff RM, Cua DJ, Bergmann CC. 2012. IFN-gamma protects from lethal IL-17 mediated viral encephalomyelitis independent of neutrophils. J Neuroinflammation 9:104. https:// doi.org/10.1186/1742-2094-9-104
69. Zhou J, Stohlman SA, Hinton DR, Marten NW. 2003. Neutrophils promote mononuclear cell infiltration during viral-induced encephalitis. J Immunol 170:3331-3336. https://doi.org/10.4049/jimmunol.170.6.3331
70. Segal AW. 2005. How neutrophils kill microbes. Annu Rev Immunol 23:197-223. https://doi.org/10.1146/annurev.immunol.23.021704 .115653
71. Steinbach K, Piedavent M, Bauer S, Neumann JT, Friese MA. 2013. Neutrophils amplify autoimmune central nervous system infiltrates by maturing local APCs. J Immunol 191:4531-4539. https://doi.org/10 .4049/jimmunol.1202613
72. Pierson ER, Wagner CA, Goverman JM. 2016. The contribution of neutrophils to CNS autoimmunity. Clin Immunol https://doi.org/10.1016/j .clim.2016.06.017
73. Simmons SB, Liggitt D, Goverman JM. 2014. Cytokine-regulated neutrophil recruitment is required for brain but not spinal cord inflammation during experimental autoimmune encephalomyelitis. J Immunol 193: 555-563. https://doi.org/10.4049/jimmunol.1400807
74. Gruol DL, Vo K, Bray JG. 2014. Increased astrocyte expression of IL-6 or CCL2 in transgenic mice alters levels of hippocampal and cerebellar proteins. Front Cell Neurosci 8:234. https://doi.org/10.3389/fncel.2014 .00234
75. Liu MT, Armstrong D, Hamilton TA, Lane TE. 2001. Expression of Mig (monokine induced by interferon-gamma) is important in T lymphocyte recruitment and host defense following viral infection of the central nervous system. J Immunol 166:1790-1795. https://doi.org/10.4049/ jimmunol.166.3.1790
76. Liu MT, Chen BP, Oertel P, Buchmeier MJ, Armstrong D, Hamilton TA, Lane TE. 2000. The T cell chemoattractant IFN-inducible protein 10 is essential in host defense against viral-induced neurologic disease. J Immunol 165:2327-2330. https://doi.org/10.4049/jimmunol.165.5.2327
77. Mueller SN, Ahmed R. 2009. High antigen levels are the cause of T cell exhaustion during chronic viral infection. Proc Natl Acad Sci U S A 106:8623-8628. https://doi.org/10.1073/pnas.0809818106
78. Bergmann CC, Parra B, Hinton DR, Chandran R, Morrison M, Stohlman SA. 2003. Perforin-mediated effector function within the central nervous system requires IFN-gamma-mediated MHC up-regulation. J Immunol 170:3204-3213. https://doi.org/10.4049/jimmunol.170.6.3204
79. You M, Yu DH, Feng GS. 1999. Shp-2 tyrosine phosphatase functions as a negative regulator of the interferon-stimulated Jak/STAT pathway. Mol Cell Biol 19:2416-2424. https://doi.org/10.1128/MCB.19.3.2416
80. Kamphuis E, Junt T, Waibler Z, Forster R, Kalinke U. 2006. Type I interferons directly regulate lymphocyte recirculation and cause transient blood lymphopenia. Blood 108:3253-3261. https://doi.org/10.1182/ blood-2006-06-027599
81. Diamond MS, Kinder M, Matsushita H, Mashayekhi M, Dunn GP, Archambault JM, Lee H, Arthur CD, White JM, Kalinke U, Murphy KM, Schreiber RD. 2011. Type I interferon is selectively required by dendritic cells for immune rejection of tumors. J Exp Med 208:1989-2003. https://doi.org/10.1084/jem .20101158
82. Eriksson KK, Cervantes-Barragan L, Ludewig B, Thiel V. 2008. Mouse hepatitis virus liver pathology is dependent on ADP-ribose-1"-phosphatase, a viral function conserved in the alpha-like supergroup. J Virol 82:12325-12334. https://doi.org/10.1128/JVI.02082-08
83. Fleming JO, Trousdale MD, el-Zaatari FA, Stohlman SA, Weiner LP. 1986. Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. J Virol 58:869-875
84. Hwang M, Phares TW, Hinton DR, Stohlman SA, Bergmann CC, Min B. 2015. Distinct CD4 T-cell effects on primary versus recall CD8 T-cell responses during viral encephalomyelitis. Immunology 144:374-386. https://doi.org/10.1111/imm.12378